Healthcare Triangle, Inc. Announces Pricing of $13.0 Million Initial Public Offering

Rhea-AI Summary

Healthcare Triangle, Inc. (HCTI) has priced its initial public offering at $4.00 per share, seeking to raise approximately $13 million. The offering includes 3,262,500 shares, with a potential over-allotment option for an additional 489,375 shares.

Trading is set to commence on October 13, 2021, on the Nasdaq Capital Market. Proceeds will be allocated for acquisitions, convertible note repayment, working capital, and general corporate purposes. The offering is expected to close around October 15, 2021, pending customary conditions.

Positive

• Initial public offering priced at $4.00 per share, raising approximately $13 million.
• The company plans to use proceeds for acquisitions, working capital, and convertible note repayment.

Negative

• No current plans or agreements for any acquisitions have been disclosed.
• Potential dilution of shares with the over-allotment option.

PLEASANTON, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. ("HTI" or the "Company"), a leader in the public cloud for Hospitals, Health Systems and Life Sciences today announced the pricing of its initial public offering of 3,262,500 shares of common stock (the “Common Stock”) at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $13.0 million, prior to deducting underwriting discounts, commissions, and offering expenses. In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 489,375 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about October 15, 2021, subject to satisfaction of customary closing conditions.

The Company has received approval to list its Common Stock on The Nasdaq Capital Market, with its Common Stock trading under the symbol “HCTI”, with trading expected to begin on October 13, 2021.

The net proceeds from the initial public offering will be used for acquisitions (although the Company has no current plans, arrangements or agreements for any acquisitions), convertible note repayment, working capital, and for general corporate purposes.

EF Hutton, division of Benchmark Investments, LLC, is acting as sole book-running manager for the offering.

The Securities and Exchange Commission (“SEC”) declared effective HTI’s registration statement on Form S-1, as amended (File No. 333-259180) (the “Registration Statement”), on October 12, 2021. A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov. The offering is being made only by means of a prospectus. Electronic copies of the final prospectus relating to this offering, when available, may be obtained from EF Hutton, a division of Benchmark Investments, LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022, Attention: Syndicate Department, or via email at syndicate@efhuttongroup.com or telephone at (212) 404-7002.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Healthcare Triangle, Inc. (HTI)

Healthcare Triangle, Inc.™ (HTI) is a leading healthcare information technology company focused on advancing innovative, industry-transforming solutions in the areas of cloud services, data science, professional and managed services for the healthcare and life sciences industry. HTI reinforces healthcare progress by enabling the adoption of new technologies, data enlightenment, business agility, and response to the immediate business needs of healthcare organizations. Visit www.healthcaretriangle.com for more information.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the Company's initial public offering. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to the Company on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including, without limitation, those set forth in the Risk Factors section of the Company's Registration Statement and preliminary prospectus for the offering filed with the SEC. Thus, actual results could be materially different. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, after the date of this release, except as required by law.

Healthcare Triangle, Inc. Contact:

For Media Enquiries:

Michael Campana

michael.c@healthcaretriangle.com

Healthcare Triangle, Inc. Investor Relations:

John McNamara

john@tradigitalir.com

917-658-2602

FAQ

What are the details of Healthcare Triangle's IPO on October 12, 2021?

Healthcare Triangle priced its IPO at $4.00 per share for 3,262,500 shares, aiming to raise about $13 million.

When will Healthcare Triangle begin trading on Nasdaq?

Healthcare Triangle is expected to start trading under the symbol HCTI on October 13, 2021.

What will the proceeds from Healthcare Triangle's IPO be used for?

The proceeds will be used for acquisitions, convertible note repayment, working capital, and general corporate purposes.

Is there an over-allotment option for Healthcare Triangle's IPO?

Yes, Healthcare Triangle has granted underwriters a 45-day option to purchase an additional 489,375 shares.

What risks are associated with Healthcare Triangle's IPO?

There is no assurance that the offering will complete as described, and reliance should not be placed on forward-looking statements.